Achieve Life Sciences, Inc.ACHVNASDAQ
Loading
| Metric | Dec 20 | Dec 21 | Dec 22 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Gross Profit | -0 | 0 | 0 |
| Operating Income | -15 | -33 | -41 |
| Net Income | -15 | -33 | -42 |
| EBITDA | -14 | -33 | -40 |
| EPS Diluted | -5.39 | -4.05 | -3.95 |
| Metric | Dec 20 | Dec 21 | Dec 22 |
|---|---|---|---|
| Cash & Equivalents | 36 | 43 | 25 |
| Total Current Assets | 37 | 45 | 27 |
| Total Assets | 40 | 48 | 30 |
| Total Current Liabilities | 3 | 5 | 22 |
| Total Liabilities | 3 | 19 | 22 |
| Total Equity | 37 | 28 | 8 |
| Total Debt | 0 | 15 | 16 |
| Net Debt | -36 | -28 | -9 |
| Metric | Dec 20 | Dec 21 | Dec 22 |
|---|---|---|---|
| Operating Cash Flow | -13 | -29 | -38 |
| Capital Expenditure | -0 | 0 | 0 |
| Free Cash Flow | -13 | -29 | -38 |
| Stock-Based Comp | 1 | 2 | 3 |
| Net Change in Cash | 19 | 7 | -18 |